WST: SEC Form 10-Q filed by West Pharmaceutical Services Inc.
Stocks in this Quantisnow insightHealth Care
Historical context for WST
Across the 22 sessions after earlier WST headlines, the stock closed higher 9 times and lower 13 times, with a median move of 2.1% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | WST | SPY |
|---|---|---|---|
| Jul 22, 2026 | West Declares Quarterly Dividend | -0.2% | -0.1% |
| Jul 13, 2026 | BNP Paribas Exane initiated coverage on West Pharm with a new price target | +1.7% | -0.8% |
| Jul 7, 2026 | West to Host Second-Quarter 2026 Conference Call | -0.4% | -0.5% |
| Jul 2, 2026 | West Completes Sale and Transfer of the Manufacturing and Supply Rights for SmartDose® 3.5mL On-Body Delivery System | +0.2% | -0.1% |
| Jun 9, 2026 | West Pharm upgraded by Barclays with a new price target | +4.7% | -0.3% |
| Jun 2, 2026 | Wolfe Research resumed coverage on West Pharm with a new price targetand 1 other headline that session | -1.3% | +0.1% |
Quantisnow market dataNYSE
WST
West Pharmaceutical Services Inc.
- Market cap
- 30-day
- Sector
- Health Care
- Industry
- Medical/Dental Instruments
Get push alerts for WST
Full WST profile on Quantisnow Follow WST and get a push notification the moment its next story breaks.
Original source Picked up and delivered by Quantisnow in real time